Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ANI Pharmaceuticals Inc (NASDAQ:ANIP)

52.88
Delayed Data
As of 10:19am ET
 +1.23 / +2.38%
Today’s Change
26.80
Today|||52-Week Range
73.54
+17.19%
Year-to-Date
Will ANI Pharmaceuticals (ANIP) Continue to Surge Higher?
9:54am / Zacks.com - Paid Partner Content
Pfizer's (PFE) Trumenba Accepted for Review in the EU
May 23 / Zacks.com - Paid Partner Content
Flexion (FLXN) Zilretta Gets Positive FDA Guidance; Stock Up
8:51am / Zacks.com - Paid Partner Content
Acorda Shelves Development of Epilepsy Treatment, Plumiaz
May 23 / Zacks.com - Paid Partner Content
Baxalta Reports Positive Phase I Study Data on BAX 930
May 26 / Zacks.com - Paid Partner Content
Dicerna Pharmaceuticals (DRNA) Jumps: Stock Rises 8.7%
May 23 / Zacks.com - Paid Partner Content
Alkermes Begins Phase I Study on Immuno-Oncology Drug
May 26 / Zacks.com - Paid Partner Content
Horizon (HZNP) to Buy Global Rights to Actimmune, Stock Down
May 20 / Zacks.com - Paid Partner Content
Innocoll Stock Gains on Favorable Phase III Data on Xaracoll
May 26 / Zacks.com - Paid Partner Content
Pronai Therapeutics (DNAI) Shows Strength: Stock Rises 7.4%
May 20 / Zacks.com - Paid Partner Content
Galapagos' RA Drug Filgotinib to Enter Phase III in 3Q16
May 25 / Zacks.com - Paid Partner Content
Agios Strikes Metabolic Immuno-Oncology Deal with Celgene
May 18 / Zacks.com - Paid Partner Content
Glaxo/Innoviva Report Positive COPD Data on Relvar Ellipta
May 25 / Zacks.com - Paid Partner Content
Bristol-Myers' Opdivo Wins FDA Nod for Additional Indication
May 18 / Zacks.com - Paid Partner Content
Zacks.com featured expert Kevin Matras highlights: ANI Pharmaceuticals, KCG Holdings,...
May 25 / Zacks.com - Paid Partner Content
Nivalis Starts Dosing in Second Phase II Cystic Fibrosis Study
May 17 / Zacks.com - Paid Partner Content
AbbVie/Boehringer Report Crohn's Disease Drug Interim Data
May 25 / Zacks.com - Paid Partner Content
Trevena (TRVN) Down on Negative Phase IIb Data on TRV027
May 17 / Zacks.com - Paid Partner Content
Biodel/Albireo Limited to Combine; Focus on Liver Diseases
May 25 / Zacks.com - Paid Partner Content
Pfizer (PFE) Reveals Positive Phase III Data on Trumenba
May 16 / Zacks.com - Paid Partner Content
Should You Get Rid of AMAG Pharmaceuticals (AMAG) Now?
May 25 / Zacks.com - Paid Partner Content
Mylan to Buy Renaissance's Topical Business for about $1B
May 16 / Zacks.com - Paid Partner Content
This Value Screen Is Our Top Performer This Year
May 24 / Zacks.com - Paid Partner Content
Kite Pharma (KITE) Upgraded to Hold on Strong Fundamentals
May 13 / Zacks.com - Paid Partner Content
Xenoport to be Acquired by Arbor Pharmaceuticals; Stock Up
May 24 / Zacks.com - Paid Partner Content
Zacks Investment Ideas feature highlights: Post Holding, Facebook, Paylocity, Ani Pha...
May 13 / Zacks.com - Paid Partner Content
Pfizer Champix's Label to Include More Data, Warning Lifted
May 24 / Zacks.com - Paid Partner Content
Bayer Stops Phase II Adempas Study Due to Safety Issues
May 13 / Zacks.com - Paid Partner Content
Integra Unveils Fin-Lock Glenoid, Boosts Shoulder Arthroplasty
May 24 / Zacks.com - Paid Partner Content
Dr. Reddy's (RDY) Q4 Earnings & Revenues Decline Y/Y
May 13 / Zacks.com - Paid Partner Content